203 related articles for article (PubMed ID: 35128571)
1. Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Martella F; Cerrano M; Di Cuonzo D; Secreto C; Olivi M; Apolito V; D'Ardia S; Frairia C; Giai V; Lanzarone G; Urbino I; Freilone R; Giaccone L; Busca A; Dellacasa CM; Audisio E; Ferrero D; Beggiato E
Ann Hematol; 2022 Apr; 101(4):855-867. PubMed ID: 35128571
[TBL] [Abstract][Full Text] [Related]
2. OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients.
Libourel EJ; Klerk C; van Norden Y; de Maat MP; Kruip MJ; Sonneveld P; Löwenberg B; Leebeek FW
Thromb Res; 2016 Apr; 140 Suppl 1():S172. PubMed ID: 27161682
[TBL] [Abstract][Full Text] [Related]
3. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia.
Libourel EJ; Klerk CPW; van Norden Y; de Maat MPM; Kruip MJ; Sonneveld P; Löwenberg B; Leebeek FWG
Blood; 2016 Oct; 128(14):1854-1861. PubMed ID: 27354723
[TBL] [Abstract][Full Text] [Related]
4. A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis.
Perek S; Khatib A; Izhaki N; Khalaila AS; Brenner B; Horowitz NA
Eur J Intern Med; 2022 Jul; 101():68-75. PubMed ID: 35527180
[TBL] [Abstract][Full Text] [Related]
5. Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia.
Del Principe MI; Buccisano F; Maurillo L; Venditti D; Cefalo M; Sarlo C; Di Caprio L; Di Veroli A; Nasso D; Ceresoli E; Postorino M; Di Piazza F; Colandrea G; Conti F; Del Poeta G; Amadori S; Venditti A
Thromb Res; 2013 Nov; 132(5):511-4. PubMed ID: 24090605
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
7. Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
Mittelman M; Platzbecker U; Afanasyev B; Grosicki S; Wong RSM; Anagnostopoulos A; Brenner B; Denzlinger C; Rossi G; Nagler A; Garcia-Delgado R; Portella MSO; Zhu Z; Selleslag D
Lancet Haematol; 2018 Jan; 5(1):e34-e43. PubMed ID: 29241762
[TBL] [Abstract][Full Text] [Related]
8. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
9. Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.
Koschade SE; Stratmann JA; Steffen B; Shaid S; Finkelmeier F; Serve H; Miesbach W; Brandts CH; Ballo O
Eur J Haematol; 2023 Apr; 110(4):426-434. PubMed ID: 36573351
[TBL] [Abstract][Full Text] [Related]
10. The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival.
Hellou T; Cohen O; Avigdor A; Amitai I; Shimoni A; Misgav M; Canaani J
Ann Hematol; 2023 May; 102(5):1037-1043. PubMed ID: 36905445
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.
Ku GH; White RH; Chew HK; Harvey DJ; Zhou H; Wun T
Blood; 2009 Apr; 113(17):3911-7. PubMed ID: 19088376
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience.
Paterno G; Palmieri R; Forte V; Del Prete V; Gurnari C; Guarnera L; Mallegni F; Pascale MR; Buzzatti E; Mezzanotte V; Cerroni I; Savi A; Buccisano F; Maurillo L; Venditti A; Del Principe MI
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428732
[TBL] [Abstract][Full Text] [Related]
14. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
[TBL] [Abstract][Full Text] [Related]
15. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
Gruschkus SK; Lairson D; Dunn JK; Risser J; Du XL
Cancer; 2010 Nov; 116(22):5279-89. PubMed ID: 20665502
[TBL] [Abstract][Full Text] [Related]
16. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
Kaplan HG; Malmgren JA; Atwood MK
BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
[TBL] [Abstract][Full Text] [Related]
18. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
20. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.
De Stefano V; Sorà F; Rossi E; Chiusolo P; Laurenti L; Fianchi L; Zini G; Pagano L; Sica S; Leone G
J Thromb Haemost; 2005 Sep; 3(9):1985-92. PubMed ID: 16102104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
